Clinical profile and natural history of children with HIV infection

Indian Journal of Pediatrics

Volumn 73, Issue 3, 2006, Pages 201-204

  Lodha, Rakesh ^a   Upadhyay, Amit ^a   Kapoor, Vishal ^a   Kabra, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antiretrovirals; Children; HIV; Natural history

Indexed keywords

ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NEVIRAPINE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANAMNESIS; ANTIGEN DETECTION; BACTERIAL INFECTION; BRAIN DISEASE; CHICKENPOX; CHRONIC DIARRHEA; CONTROLLED STUDY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FAILURE TO THRIVE; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INDIA; LABORATORY TEST; MALE; MEDICAL RECORD; PNEUMOCYSTIS CARINII; PNEUMONIA; POLYMERASE CHAIN REACTION; RECURRENT FEVER; REVIEW; SYMPTOMATOLOGY; TERTIARY HEALTH CARE; TUBERCULOSIS; ADOLESCENT; ARTICLE; CHILD; DISEASE COURSE; DISEASE TRANSMISSION; NEWBORN; NUTRITIONAL STATUS; PRESCHOOL CHILD;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INDIA; INFANT, NEWBORN; MALE; NUTRITIONAL STATUS;

EID: 33746199934     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02825480     Document Type: Review

References (21)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update: December 2003. UNAIDS, WHO. 2003.
2. NACO. HIV estimates in India 2003. Data accessed from website: http://nacoonline.org/factsnfigures/hivestimates 2003.pdf on September 4 2004.
3. Madhivanan P, Mothi SN, Kumarasamy N et al. Clinical manifestations of HIV infected children. Indian J Pediatr 2003; 70:615-620.
4. Udgirkar VS, Tullu MS, Bavdekar SB, Shaharao VB, Kamat JR, Hira PR. Neurological manifestations of HIV infection. Indian Pediatr 2003; 40: 230-234.
5. Verghese VP, Cherian T, Cherian AJ et al. Clinical manifestations of HIV-1 infection. Indian Pediatr 2002; 39 : 57-63.
6. Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection. Indian Pediatr 2001; 38: 239-246.
7. Lodha R, Singhal T, Jain Y, Kabra SK, Seth P, Seth V. Pediatric HIV infection in a tertiary care center in North India: early impressions. Indian Pediatr 2000; 37: 982-986.
8. Anonymous. Recommendations for the selection and use of HIV antibody tests. WHO Weekly Epidemiol Rec 1992; 20: 145-149.
9. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatr Infect Dis J 1993; 12: 513-522.
10. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected children. Antiretroviral therapy and medical management of pediatric HIV infection. Pediatrics 1998; 102:1005-1062.
11. USPHS/IDSA Prevention of Opportunistic Infections Working Group. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary. MMWR 1995; 44 (No. RR 8).
12. 1997 USPHS/IDSA Report on Prevention of Opportunistic Infections in Patients Infected with Human Immunodeficiency Virus. Pediatrics 1998; 102: 1064-1086.
13. Barnhart HX, Caldwell MB, Thomas P et al. Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996; 97: 710-716.
14. Tovo PA, Martino M, Gabiano C et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992; 339: 1249-1252.
15. Italian Register for HIV infection in children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994; 343: 191-195.
16. Emodi IJ, Okafor GO. Clinical manifestations of HIV infection in children at Enugu, Nigeria. J Trop Pediatr 1998; 44: 73-76.
17. Lambert HJ, Friesen H. Clinical features of pediatric AIDS in Uganda. Ann Trop Paediatr 1989; 9: 1-5.
18. Berhane R, Bagenda D, Marum L et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics. 1997; 100:e7.
19. Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002; 109: e25.
20. Buchacz K, Cervia JS, Lindsey JC et al. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics 2001; 108: e72.
21. Van Rossum AM, Gaakeer MI, Verweel S et al. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors. Pediatr Infect Dis J 2003; 22: 70-76.